Strategic Partnerships Osstell is a global leader in implant stability measurement with a history of collaborations including Neoss and W&H, indicating strong receptivity to OEM and distribution partnerships that could expand penetration in dental implant clinics and labs.

Clinical Value The ISQ-based, non-invasive measurement technology is validated by over a thousand publications, underscoring clear clinical benefits and a compelling value proposition for clinics seeking predictable implant outcomes and reduced treatment times.

Product Expansion Past launches such as Osstell IDx Pro and SmartPegs for BLX indicate willingness to extend hardware/software offerings; there are opportunities to upsell integration with partner implant systems and analytics features for broader adoption.

Market Positioning As a leading innovator from Gothenburg with deep clinical validation and global presence, Osstell is well-placed to target mid to large dental practices, hospital dental departments, and implant centers seeking established stability assessment workflows.

Growth Opportunities With revenue in the 0-1M range and existing OEM collaborations, there is room to scale through broader distribution agreements, licensing of ISQ technology, and bundled offerings with implant system manufacturers and dental service organizations.